摘要 : Factor eight inhibitor bypassing activity (aPCC) is recommended as a non-specific reversal agent for direct oral anticoagulants (DOACs) according to the 2017 American College of Cardiology (ACC) guidelines for reversal of anticoag... 展开
作者 | Whitaker~ Caitlyn McKinney~ Amanda Bollig~ Reagan Hieb~ Nathan Roberts~ R. Frank~ Jr. Rowe~ A. Shaun |
---|---|
作者单位 | |
期刊名称 | 《Journal of thrombosis and thrombolysis》 |
总页数 | 7 |
语种/中图分类号 | 英语 / R74 |
关键词 | Thromboembolism Blood coagulation factors Hemorrhage Factor Xa inhibitors MANAGEMENT GUIDELINE |
馆藏号 | N2007EPST0000943 |